ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Gastroenterology

Top Gastroenterology Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BOB SOUDER MD

Gastroenterology

13,277

$548K

1887
1209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 31%

$41
Average prescription price

Avg: $126

BRAD BLANKENSHIP M.D.

Gastroenterology

13,057

$577K

311
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

31%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 31%

$44
Average prescription price

Avg: $126

SAMUEL PLUCKER M.D.

Gastroenterology

10,902

$790K

670
444 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 31%

$72
Average prescription price

Avg: $126

ROBERT KERLAN M.D.

Gastroenterology

10,179

$673K

524
464 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 31%

$66
Average prescription price

Avg: $126

FERDINAND BALATICO M.D.

Gastroenterology

8,372

$364K

286
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 31%

$43
Average prescription price

Avg: $126

RICHARD SADOWITZ M.D.

Gastroenterology

5,380

$856K

688
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 31%

$159
Average prescription price

Avg: $126

ALLAN MENACHEM MD

Gastroenterology

5,280

$284K

679
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 31%

$54
Average prescription price

Avg: $126

AMIT CHOKSI MD

Gastroenterology

4,323

$413K

1270
947 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 31%

$95
Average prescription price

Avg: $126

JAY PHILIPPOSE M.D.

Gastroenterology

3,859

$549K

598
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 31%

$142
Average prescription price

Avg: $126

JOHN STANCHER MD

Gastroenterology

3,696

$446K

788
597 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 31%

$121
Average prescription price

Avg: $126

MICHAEL ELLIS MD

Gastroenterology

3,328

$663K

685
357 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 31%

$199
Average prescription price

Avg: $126

HENRY PAIK M.D.

Gastroenterology

3,286

$445K

824
543 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 31%

$135
Average prescription price

Avg: $126

ROBERT MCCLURE MD

Gastroenterology

3,098

$445K

603
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 31%

$144
Average prescription price

Avg: $126

MORRIS BAROCAS M.D.

Gastroenterology

3,031

$1.09M

512
223 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 31%

$358
Average prescription price

Avg: $126

JEFFREY FENYVES M.D.

Gastroenterology

2,999

$380K

730
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 31%

$127
Average prescription price

Avg: $126

MICHAEL SULLIVAN M.D.

Gastroenterology

2,960

$257K

950
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 31%

$87
Average prescription price

Avg: $126

MICHAEL GOODMAN M.D.

Gastroenterology

2,794

$390K

621
489 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 31%

$140
Average prescription price

Avg: $126

MUNFORD YATES M.D.

Gastroenterology

2,770

$382K

496
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 31%

$138
Average prescription price

Avg: $126

JEFFREY ESKIND M.D.

Gastroenterology

2,741

$196K

302
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 31%

$71
Average prescription price

Avg: $126

SAID NABHAN MD

Gastroenterology

2,728

$528K

729
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 31%

$194
Average prescription price

Avg: $126

ALAN SHIKOH MD

Gastroenterology

2,605

$241K

670
566 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 31%

$93
Average prescription price

Avg: $126

ROBERT HERRING MD

Gastroenterology

2,589

$394K

430
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 31%

$152
Average prescription price

Avg: $126

PAUL BRUNDAGE D.O.

Gastroenterology

2,514

$395K

487
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 31%

$157
Average prescription price

Avg: $126

ARVINDER SACHDEV MD

Gastroenterology

2,501

$1.03M

559
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 31%

$411
Average prescription price

Avg: $126

KENNETH FIELDS MD

Gastroenterology

2,482

$304K

369
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 31%

$122
Average prescription price

Avg: $126

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank